Skip to main content

Table 3 Interventions ranking the treatments names column follow the league table (which arranges the presentation of summary estimates by ranking the treatments in order of most pronounced impact on the outcome under consideration) the numerical values represents the cumulative results of the probability of being best in which the highest score is 1 or 100% (see Rankogram)

From: Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis

Treatment

SUCRA

Treatment

SUCRA

Allopurinol

0.9647

NaHCO3

0.3419

MESNA

0.9427

Pentoxifylline

0.3391

PGE1

0.7809

I.V Hydration

0.3124

α-tocopherol

0.7614

Placebo

0.2694

Oxygen

0.7527

Oral Hydration

0.2517

K/Na citrate

0.7469

Hypothermia

0.2021

Trimetazidine

0.7151

Control

0.1658

Probucol

0.7042

Amlodipine and Valsartan

0.05485

γ-tocopherol

0.689

ACEI

0.5783

BNP

0.6767

Aminophylline

0.6593

Anisodamine

0.6594

Iloprost

0.7481

Nicorandil

0.6442

Acetazolamide

0.6242

Theophylline

0.629

ANP

0.3291

RIPC

0.5692

Zinc

0.198

Statins

0.5497

Dialysis

0.4319

MgSO4

0.5177

Fenoldopam

0.2296

NAC

0.4592

ERAs

0.06734

Nebivolol

0.4543

CCB

0.7249

Ascorbic Acid

0.4433

Dopamine

0.1916

Alpha-Lipoic Acid

0.4322

Mannitol

0.1905

Furosemide

0.4027

Cordyceps

0.4459

Glutathione

0.3554

Silymarin

0.7934

Analysis

Random Effects (Vague)